Correlation Between Brickell Biotech and Annovis Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Brickell Biotech and Annovis Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Brickell Biotech and Annovis Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Brickell Biotech and Annovis Bio, you can compare the effects of market volatilities on Brickell Biotech and Annovis Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Brickell Biotech with a short position of Annovis Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Brickell Biotech and Annovis Bio.

Diversification Opportunities for Brickell Biotech and Annovis Bio

0.67
  Correlation Coefficient

Poor diversification

The 12 months correlation between Brickell and Annovis is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Brickell Biotech and Annovis Bio in the same portfolio assuming nothing else is changed. The correlation between historical prices or returns on Annovis Bio and Brickell Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Brickell Biotech are associated (or correlated) with Annovis Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annovis Bio has no effect on the direction of Brickell Biotech i.e., Brickell Biotech and Annovis Bio go up and down completely randomly.

Pair Corralation between Brickell Biotech and Annovis Bio

Considering the 90-day investment horizon Brickell Biotech is expected to under-perform the Annovis Bio. But the stock apears to be less risky and, when comparing its historical volatility, Brickell Biotech is 1.61 times less risky than Annovis Bio. The stock trades about -0.05 of its potential returns per unit of risk. The Annovis Bio is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  2,182  in Annovis Bio on February 15, 2022 and sell it today you would lose (1,203)  from holding Annovis Bio or give up 55.13% of portfolio value over 90 days.
Time Period12 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.63%
ValuesDaily Returns

Brickell Biotech  vs.  Annovis Bio

 Performance (%) 
      Timeline 
Brickell Biotech 
Brickell Performance
0 of 100
Over the last 90 days Brickell Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's fundamental drivers remain nearly stable which may send shares a bit higher in June 2022. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Brickell Price Channel

Annovis Bio 
Annovis Performance
0 of 100
Over the last 90 days Annovis Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in June 2022. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Annovis Price Channel

Brickell Biotech and Annovis Bio Volatility Contrast

 Predicted Return Density 
      Returns 

Pair Trading with Brickell Biotech and Annovis Bio

The main advantage of trading using opposite Brickell Biotech and Annovis Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Brickell Biotech position performs unexpectedly, Annovis Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annovis Bio will offset losses from the drop in Annovis Bio's long position.
The idea behind Brickell Biotech and Annovis Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go